Yuning Liao

发表

Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide

Jinbao Liu, Xuejun Wang, Hongbiao Huang, 2019, Journal of Experimental & Clinical Cancer Research.

HSP90β Impedes STUB1‐Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma

Jia Hua Cheng, Hongbiao Huang, Y. Liao, 2023, Advanced science.

Selective degradation of AR-V7 to overcome castration resistance of prostate cancer

Yuanfei Deng, Yuan-Fei Liu, Hongbiao Huang, 2021, Cell Death & Disease.

Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination

Jinbao Liu, D. Tang, Hongbiao Huang, 2018, Oncogene.

Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor

Jinbao Liu, Hongbiao Huang, Ningning Liu, 2017, Cell Death & Disease.

USP10 deletion inhibits macrophage-derived foam cell formation and cellular-oxidized low density lipoprotein uptake by promoting the degradation of CD36

Hongbiao Huang, Qiong Xu, Ningning Liu, 2020, Aging.

Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy

Jinbao Liu, D. Tang, Yuan-Fei Liu, 2020, Theranostics.

A new role of GRP75-USP1-SIX1 protein complex in driving prostate cancer progression and castration resistance

Jinbao Liu, Yuanfei Deng, D. Tang, 2021, Oncogene.

Combined therapeutic effects of bortezomib and anacardic acid on multiple myeloma cells via activation of the endoplasmic reticulum stress response.

Jinbao Liu, Hongbiao Huang, Ningning Liu, 2016, Molecular medicine reports.

USP10 modulates the SKP2/Bcr-Abl axis via stabilizing SKP2 in chronic myeloid leukemia

Jinbao Liu, D. Tang, Hongbiao Huang, 2019, Cell Discovery.

Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression

Jinbao Liu, D. Tang, Hongbiao Huang, 2023, International journal of biological sciences.

A SIX1 degradation inducer blocks excessive proliferation of prostate cancer

Jinbao Liu, Yuanfei Deng, Hongbiao Huang, 2022, International journal of biological sciences.

USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells

Jinbao Liu, Yuanfei Deng, D. Tang, 2021, Journal of experimental & clinical cancer research : CR.

Bilirubin Restrains the Anticancer Effect of Vemurafenib on BRAF-Mutant Melanoma Cells Through ERK-MNK1 Signaling

Jinbao Liu, D. Tang, G. Wen, 2021, Frontiers in Oncology.

The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression

Jinbao Liu, Yuan-Fei Liu, Hongbiao Huang, 2021, Cell Death & Disease.

ERα is a target for butein-induced growth suppression in breast cancer.

Bin Liu, Yuan-Fei Liu, Hongbiao Huang, 2020, American journal of cancer research.

Targeting SKP2/Bcr-Abl pathway with Diosmetin suppresses chronic myeloid leukemia proliferation.

Jinbao Liu, Yuan-Fei Liu, Hongbiao Huang, 2020, European journal of pharmacology.

Targeting ERα degradation by L-Tetrahydropalmatine provides a novel strategy for breast cancer treatment

B. Liu, Hongbiao Huang, Qiong Xu, 2020, International journal of biological sciences.

Deubiquitination and stabilization of Estrogen Receptor α by Ubiquitin-Specific Protease 7 promotes breast tumorigenesis.

Q. Dou, Jinbao Liu, Yuan-Fei Liu, 2019, Cancer letters.

Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo

D. Zang, Jinbao Liu, Xiaofen Li, 2015, Oncotarget.

Auranofin lethality to prostate cancer includes inhibition of proteasomal deubiquitinases and disrupted androgen receptor signaling

Jinbao Liu, Yuan-Fei Liu, Xuejun Wang, 2019, European journal of pharmacology.

Bilirubin neurotoxicity is associated with proteasome inhibition

Jinbao Liu, Y. Nie, P. Zhou, 2017, Cell Death & Disease.

A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy

D. Zang, Q. Dou, Jinbao Liu, 2016, Oncogene.

Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer

Jinbao Liu, Yuan-Fei Liu, Xuejun Wang, 2019, Journal of Experimental & Clinical Cancer Research.

Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy

D. Zang, Jinbao Liu, Zhiming He, 2016, Biochemical pharmacology.

Synergistic effects of gefitinib and thalidomide treatment on EGFR-TKI-sensitive and -resistant NSCLC.

Jinbao Liu, Yuan-Fei Liu, Xuejun Wang, 2019, European journal of pharmacology.

A novel deubiquitinase inhibitor b-AP15 triggers apoptosis in both androgen receptor-dependent and -independent prostate cancers

Xiaolan Zhang, Jinbao Liu, Hongbiao Huang, 2017, Oncotarget.

Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer

Jinbao Liu, Yuan-Fei Liu, Xuejun Wang, 2018, Oncogenesis.

Novel use of clinical drugs: Deubiquitinase inhibitor auranofin and disulfiram show synergistic anti-tumor effects in vitro and in vivo

Jinbao Liu, Hongbiao Huang, Ningning Liu, 2016 .

Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases

D. Zang, Jinbao Liu, Xiaofen Li, 2017, Oncotarget.

Gambogic acid induces apoptosis in diffuse large B-cell lymphoma cells via inducing proteasome inhibition

D. Zang, Jinbao Liu, Xiaofen Li, 2015, Scientific Reports.

Ubiquitin-specific protease 14 regulates cardiac hypertrophy progression by increasing GSK-3β phosphorylation.

B. Liu, Jinbao Liu, R. Chai, 2016, Biochemical and biophysical research communications.

Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition

Jinbao Liu, Yanling Li, Yan Liu, 2017, Journal of experimental & clinical cancer research : CR.

METTL14-mediated m6A modification enhances USP22-ERα axis to drive breast cancer malignancy.

Hongbiao Huang, Wenshuang Sun, Xiaoyue He, 2024, Pharmacological research.